Insider filing · ATTO

Colin Walsh bought $10.3M of Attovia Therapeutics (ATTO)

Executed Aug 5, disclosed Aug 28, 23 days later, against a two-business-day limit.

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

CW Colin Walsh Director profile →

Colin Walsh (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 2 sales, 2 filed past the two-business-day deadline), most often in Attovia Therapeutics, Inc. Common Stock (ATTO). Across 1 priced purchase filing, the average 21-session return was +10.1% from execution and +26.2% from disclosure (delay-adjusted; derived). The largest single filing was $10.3M of ATTO (585,000 sh across 2 lots, as filed), executed Aug 5.

ATTO Attovia Therapeutics, Inc. Common Stock ATTO · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→